VERA THERAPEUTICS, INC.
Last · NASDAQ$26.74-0.05 (-0.19%)close · yahoo · 11h ago
Market cap$1.93B72.1M sh
P/E · TTM-4.6fwd -6.3 · eps -5.87 · loss
Beta1.05vs S&P 500
Div yield0.00%annual · TTM
52w range
$23.05$56.05
Volume1.5Msession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-26
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.5 years
- Accumulated Deficit High — Accumulated deficit / equity 126%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.61
Est. revenue
3.7M
Earnings transcripts
Press & signals
- GlobeNewswire
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans